Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zaporizhia Medical Academy OffiledCriticalZaporizhia Medical Academy Of
Priority to UA20040402788UpriorityCriticalpatent/UA6306U/en
Publication of UA6306UpublicationCriticalpatent/UA6306U/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
The method for treating the disorders of hepatic blood circulation in the patients with the arterial hypertension and the heart failure comprises the use of angiotensin-converting enzyme inhibitor, diuretic, beta-adrenoblocker, and Enoxaparin (Clexan) subcutaneously at a daily dose of 0.5 mg/kg.
UA20040402788U2004-04-152004-04-15Method for treating disorders of hepatic blood circulation in patients with arterial hypertension and heart failure
UA6306U
(en)
Use of N-acetylcysteine for the preparation of a medicament suitable for the intravenous administration to prevent oxidative stress in dialysed patients
Use of aqueous extract of red vine leaves for preventing transition from clinically insignificant early stages of chronic venous insufficiency to stages i, ii or iii